España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ANI Pharmaceuticals
ANIP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$58.59
0.00
0.00%
Pre-Market: 4:00 PM EDT
Get Report
Comment
ANI Pharmaceuticals (ANIP) Forecast
News
Earnings
ANI Pharmaceuticals (ANIP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ANI Pharmaceuticals (NASDAQ:ANIP) Stock
ANI Pharmaceuticals Stock (NASDAQ: ANIP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 16, 2025
Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, January 13, 2025
Alcami Announces Bill Humphries To Retire; Bo...
Benzinga Newsdesk
ANI Pharma Expects Q4 Purified Cortrophin Gel...
Benzinga Newsdesk
Thursday, January 02, 2025
ANI Pharmaceuticals Announced That Following ...
Benzinga Newsdesk
Wednesday, December 11, 2024
Where ANI Pharmaceuticals Stands With Analysts
Benzinga Insights
Leerink Partners Initiates Coverage On ANI Ph...
Benzinga Newsdesk
Monday, November 11, 2024
HC Wainwright & Co. Reiterates Buy on ANI Pha...
Benzinga Newsdesk
Friday, November 08, 2024
ANI Pharmaceuticals Expects 2024 Adjusted EPS...
Benzinga Newsdesk
ANI Pharmaceuticals Expects 2024 Revenues Of ...
Benzinga Newsdesk
ANI Pharmaceuticals Q3 2024 Adj EPS $1.34 Bea...
Benzinga Newsdesk
Thursday, November 07, 2024
A Peek at ANI Pharmaceuticals's Future Earnings
Benzinga Insights
Friday, October 25, 2024
ANI Pharmaceuticals Says Following Final Appr...
Nabaparna Bhattacharya
Tuesday, October 22, 2024
Critical Insights From ANI Pharmaceuticals Analyst Ratings: What You Need To Know
Benzinga Insights
Truist Securities Maintains Hold on ANI Pharm...
Benzinga Newsdesk
Friday, October 18, 2024
Avadel Obtains FDA Nod for Label Expansion Of Narcolepsy Drug Lumryz
Zacks
Thursday, October 17, 2024
Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU
Zacks
Wednesday, October 16, 2024
MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study
Zacks
Friday, October 11, 2024
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential
Vandana Singh
Peeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst Insights
Benzinga Insights
Piper Sandler Initiates Coverage On ANI Pharm...
Benzinga Newsdesk
Tuesday, October 08, 2024
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
Zacks
Wednesday, October 02, 2024
IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag
Zacks
Thursday, September 26, 2024
ANI Pharmaceuticals Reports FDA Approval And ...
Benzinga Newsdesk
Tuesday, September 24, 2024
BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal
Zacks
Wednesday, September 18, 2024
Raymond James Maintains Outperform on ANI Pha...
Benzinga Newsdesk
Tuesday, September 17, 2024
In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on ANI Pha...
Benzinga Newsdesk
Friday, September 13, 2024
Ani Pharmaceuticals Launches Promethazine Hyd...
Nabaparna Bhattacharya
Wednesday, September 11, 2024
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
Avi Kapoor
ANI Pharmaceuticals And Alimera Sciences Anno...
Benzinga Newsdesk
Truist Securities Downgrades ANI Pharmaceutic...
Benzinga Newsdesk
Tuesday, September 10, 2024
ANI Pharmaceuticals Updates On Alimera Scienc...
Benzinga Newsdesk
Alimera Sciences Takes Legal Action Against A...
Benzinga Newsdesk
Wednesday, August 07, 2024
ANI Pharmaceuticals shares are trading lower ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ANI Pha...
Benzinga Newsdesk
ANI Pharmaceuticals Announced Its Intention T...
Benzinga Newsdesk
Tuesday, August 06, 2024
ANI Pharmaceuticals shares are trading higher...
Benzinga Newsdesk
ANI Pharmaceuticals Forecasts 2024 Adjusted E...
Benzinga Newsdesk
ANI Pharmaceuticals Forecasts 2024 Net Revenu...
Benzinga Newsdesk
ANI Pharmaceuticals Q2 2024 Adj. EPS $1.02 Be...
Benzinga Newsdesk
Tuesday, July 16, 2024
Lisata Stock Rallies More Than 30% YTD: Here's Why
Zacks
Monday, July 15, 2024
ANI's Generic L-Glutamine Oral Powder Hits Ma...
Benzinga Newsdesk
Tuesday, July 02, 2024
ANI Pharmaceuticals Announces FDA Approval An...
Benzinga Newsdesk
Wednesday, June 26, 2024
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on ANI Phar...
Benzinga Newsdesk
Tuesday, June 25, 2024
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
Avi Kapoor
Monday, June 24, 2024
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
Vandana Singh
ANI Pharma to Snap Alimera Sciences Valuing T...
Benzinga Newsdesk
Thursday, June 06, 2024
Insider Selling: Stephen P Carey Unloads $317K Of ANI Pharmaceuticals Stock
Benzinga Insights
Show More
